3 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 3 of 3 clinical reviews.
Evidence-based guide to thymosin alpha-1 (thymalfasin) dosing considerations in Black and African ancestry populations, covering pharmacogenomics, immune response variability, and clinical monitoring.
Evidence-based review of Thymosin Alpha-1 (thymalfasin) efficacy differences in East Asian populations, including pharmacogenomic factors, HBV trial data, and dosing considerations.
Evidence-based review of Thymosin Alpha-1 (thymalfasin) efficacy differences in South Asian populations, covering pharmacogenomics, dosing considerations, immune response variation, and clinical trial subgroup data.